Why we are helping patients with lung cancer symptoms self-refer for a chest X-ray Pharmacies in Leeds are helping to diagnose lung cancer earlier by piloting a service that allows patients with red-flag symptoms to refer themselves to hospital for testing.…
Varenicline planned for return but ‘not before’ end of 2024, says manufacturer Pfizer has said smoking cessation therapy varenicline will be reintroduced to the UK, after being withdrawn in October 2021.…
Boots UK shuts online mental health service to new patients Exclusive: The multiple launched the online service in 2022, but says it is now at capacity and will be “temporarily paused” to new patients.…
Regulator approves first injectable treatment for prevention of HIV Cabotegravir has been approved as pre-exposure prophylaxis in the UK in both tablet and injectable form.…
Best practice for medicines use in neonates An overview of pharmacokinetic and pharmacodynamic considerations when treating neonates, and the impacts on drug absorption, metabolism and elimination.…
Number of Pharmacy First consultations in Scotland increases by 60% in three years Data show an increase in the use of the NHS Pharmacy First service in Scotland across gender, age and deprivation quintiles.…
NICE recommends voxelotor for sickle cell treatment, reversing previous decision The National Institute for Health and Care Excellence said it was able to recommend the sickle cell treatment following a reduction in its price.…
Juvenile idiopathic arthritis: biologic disease modifying anti-rheumatic drugs Biologic disease modifying anti-rheumatic drugs have greatly changed the treatment and outcomes of juvenile idiopathic arthritis; there are many considerations for their use that pharmacists should be aware of.…
MHRA announces development of tool for public to report websites selling fake medicines The Medicines and Healthcare products Regulatory Agency said the new checking tool will allow it to investigate and take enforcement action against unsafe websites.…
Community pharmacy training sites without access to a prescribing supervisor advised to withdraw placements In a statement, the National Pharmacy Association said the chances of sites securing a designated prescribing practitioner in time for the 2025/2026 foundation year “are slim”.…
